How has BioLife Solutions's investments - amortized cost basis changed year-over-year?

BioLife Solutions's investments - amortized cost basis increased by 118.4% year-over-year, from $40.66M to $88.79M.

What is the long-term trend for BioLife Solutions's investments - amortized cost basis?

Over 3 years (2022 to 2025), BioLife Solutions's investments - amortized cost basis has grown at a 24.9% compound annual growth rate (CAGR), from $44.64M to $87.01M.

BioLife Solutions BLFS Investments - Amortized Cost Basis

Investments - Amortized Cost Basis at other companies

Bio-Rad LaboratoriesBIO

——

Other financials

Income statement

See full

Revenue$27.5M+24.7%

Gross profit$17.5M+18.2%

Operating income$27.0K+105%

Net income$1.2M+365%

EPS (diluted)$0.02—

Balance sheet

See full

Cash & equivalents$22.8M-65.9%

Total debt$17.4M-35.6%

Total equity$372.2M+5.6%

Total assets$400.9M+1.5%

Cash flow

See full

Operating cash flow-$491.0K-128%

CapEx$167.0K-4.6%

Free cash flow-$658.0K-142%

Valuation

See full

Market cap$1.34B+33.1%

Enterprise value$1.34B+38.1%

P/S13.5×+0.6×

Profitability

See full

Gross margin66.9%—

Operating margin-16.7%—

Net margin-68.7%—

FCF margin-15.9%+18.7pp

Returns & leverage

See full

Return on equity-14.5%-4.7pp

Debt / equity0×0.0×

Current ratio7.3×+2.6×

Where this comes from

Reported directly by BioLife Solutions in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis.

The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioLife Solutions's investments - amortized cost basis.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioLife Solutions's investments - amortized cost basis?: BioLife Solutions (BLFS) reported investments - amortized cost basis of $88.79M in Q1 2026.
How has BioLife Solutions's investments - amortized cost basis changed year-over-year?: BioLife Solutions's investments - amortized cost basis increased by 118.4% year-over-year, from $40.66M to $88.79M.
What is the long-term trend for BioLife Solutions's investments - amortized cost basis?: Over 3 years (2022 to 2025), BioLife Solutions's investments - amortized cost basis has grown at a 24.9% compound annual growth rate (CAGR), from $44.64M to $87.01M.